Sigilon Therapeutics Inc (SGTX)


Stock Price Forecast

Aug. 11, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Sigilon Therapeutics Inc chart...

About the Company

harnessing the full power of cell therapeutics. cambridge, ma

Exchange

NASDAQ

$17M

Total Revenue

88

Employees

$56M

Market Capitalization

-16.20

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SGTX News

Sigilon Therapeutics’ stock soars 550% after Eli Lilly agrees to acquire company

9mon ago, source: Hosted on MSN

Eli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to $309.6 million, sending Sigilon’s stock up 550%. The deal for Sigilon which is expected to ...

Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights

1mon ago, source: ADVFN

Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported ...

Delcath Systems Appoints Martha Rook As COO

9d ago, source:

Delcath Systems Inc. (DCTH) said it appointed Martha Rook as its Chief Operating Officer. Martha Rook has more than 25 years of ...

Douglas G. Cole's Net Worth

9d ago, source: Benzinga.com

Foghorn Therapeutics Inc., Denali Therapeutics Inc., and Sigilon Therapeutics, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro!

12 Best Biotech Penny Stocks to Invest In

4d ago, source: InvestingChannel on MSN

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these ...

Carriage Servs Stock (NYSE:CSV), Quotes and News Summary

1mon ago, source: Benzinga.com

Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14. ...

CVKD Cadrenal Therapeutics, Inc.

1d ago, source: Seeking Alpha

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart ...

Omega Therapeutics Inc OMGA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

ZVRA Zevra Therapeutics, Inc.

1d ago, source: Seeking Alpha

Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes ...

Leap Therapeutics Inc LPTX

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Sarepta Therapeutics Inc.

13d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Akero Therapeutics Inc (AKRO)

13d ago, source: Investing

Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc. (NASDAQ:AKRO), has recently sold shares of the company's common stock, generating over $18,000 in the... Akero Therapeutics ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...